PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.\', \'Department of Neurology, Faculty of Medicine, University of Bonn, Bonn, Germany.\', \'Institute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.\', \'German Center for Infection Research (DZIF), Berlin, Germany.\', \'Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. monique.breteler@dzne.de.\', \'Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, Bonn, Germany. monique.breteler@dzne.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-22351-5
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33837204
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all